Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Scientists believe that medication given through the nose has the potential to be more effective because it attacks or blocks ...
Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.
Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback